Humacyte, Inc.
NASDAQ:HUMA
Overview | Financials
Company Name | Humacyte, Inc. |
Symbol | HUMA |
Currency | USD |
Price | 4.68 |
Market Cap | 602,166,240 |
Dividend Yield | 0% |
52-week-range | 2.48 - 9.97 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
Website | https://www.humacyte.com |
An error occurred while fetching data.
About Humacyte, Inc.
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD